Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...

Eton Pharmaceuticals’ NDA for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA ...

Teos will look to distribute its cash reserves to shareholders, along with proceeds raised from selling pipeline assets.

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

The EC has granted approval for the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) ...

Scynexis has resumed dosing of its Brexafemme (ibrexafungerp) drug in a Phase III trial after a 19-month clinical hold by the ...

The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta Pharma’s C-CAR168.

GlycoEra has closed an oversubscribed Series B financing round, raising $130m, to support its lead IgG4-targeted protein ...

The US Centers for Disease Control and Prevention (CDC) is no longer recommending Covid-19 vaccines to healthy children and ...

In the race to decarbonize the global economy, advanced materials are no longer a luxury – they’re a necessity.

PL logistics need to invest in new technology and upskilling programs to scale their cell and gene therapy services.